查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1971326

生物基聚丙烯医疗设备市场－全球产业规模、份额、趋势、机会和预测：按应用、地区和竞争格局划分，2021-2031年

Bio-based Polypropylene in Medical Devices Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Application (Heart Valve Structures, Surgery Sutures, Surgical Mesh, Others), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球医疗设备用生物基聚丙烯市场预计将从 2025 年的 119.6 亿美元成长到 2031 年的 204.1 亿美元，复合年增长率为 9.32%。

用于医疗领域的生物基聚丙烯是一种热塑性聚合物，由玉米、甘蔗和废油等可再生资源製成，旨在减少碳排放，同时提供与化石基聚丙烯相当的机械性能和耐化学性。推动该市场发展的关键因素包括医疗产业迫切需要减少对环境的影响，以及对永续采购日益严格的监管。这些因素不仅显示了一种技术趋势，也预示着供应链脱碳结构转型的基础。欧洲生质塑胶协会的报告显示，到2024年，全球生质塑胶产能将达到247万吨，凸显了扩大工业规模以满足永续采购需求的必要性。

市场概览
预测期 2027-2031
市场规模：2025年 119.6亿美元
市场规模：2031年 204.1亿美元
复合年增长率：2026-2031年 9.32%
成长最快的细分市场 手术缝合线
最大的市场 北美洲

另一方面，市场扩张的一大障碍是医用级材料必须经过严格的检验和再认证程序。以生物基替代品取代传统聚丙烯需要进行全面的测试，以确保符合监管要求和生物相容性，这会导致成本大幅增加，并延缓现有製造商进入市场。由于病患安全至关重要，这些生物基替代品在被采用之前必须经过严格审查，儘管它们具有明显的环保优势，但这仍然阻碍了它们取代传统塑胶。

市场驱动因素

严格的法规结构的实施，旨在促进永续材料的使用，是重塑全球医疗设备用生物基聚丙烯市场的主要驱动力。随着医疗保健系统向脱碳方向发展，采购要求积极要求减少范围3排放，迫使製造商从化石资源转向生物基聚合物，以确保合规并维持市场进入。例如，英国国家医疗服务体系（NHS England）已扩大了供应商公布「碳减排计划」的要求，自2024年4月起，所有新采购项目均需提交该计划，这直接要求医疗设备供应商提供检验的排放证明。根据Think Global Health的数据显示，截至2024年2月，医疗保健产业约占全球温室气体排放总量的4.4%，凸显了材料转型的迫切性，而这项转型至关重要。

此外，专注于生物材料探索和商业化的策略性产业合作正在透过克服供应链和检验障碍来加速市场扩张。化学品製造商正与医疗设备製造商直接合作，开发符合严格生物相容性要求的医用级生物基聚丙烯，同时提高产能。这些合作确保了生物基材料在技术上可靠，并商业性以足够的数量实现大规模生产。例如，利安德巴塞尔在其2024年永续发展报告中重申了其目标，即到2030年每年生产和销售至少200万吨由回收和可再生原材料衍生的聚合物。这种在策略伙伴关係支援下实现的扩张对于在包装和一次性注射器等大批量应用领域取代传统聚丙烯至关重要。

市场挑战

医用级材料所需的全面检验和再认证流程是生物基聚丙烯市场成长的主要障碍。医疗设备製造商必须遵守严格的安全标准，并且在用生物基替代品取代传统聚丙烯时，必须启动强制性的、广泛的测试通讯协定。这些流程包括全面的生物相容性评估和长期稳定性测试，以确保新材料不会对病人安全构成威胁。由于再认证需要大量资金，且核准进度难以预测，製造商为了避免营运中断，不得不优先选择成熟的化石燃料供应链，而非永续的替代方案。

监管瓶颈正显着减缓生物基医疗设备的商业化进程，造成原料供应与实际市场渗透率之间的差距。有效克服这些监管障碍所需的漫长流程，实际上延缓了旨在实现产品线脱碳的企业的投资回报。根据欧洲医疗技术协会（MedTech Europe）的报告显示，到2024年，根据《医疗设备法规》（MDR），改良型医疗技术的平均认证时间将超过18个月。这种延误阻碍了製造商采用生物基聚丙烯，因为市场准入的延迟所带来的竞争风险超过了永续采购带来的即时效益。

市场趋势

经ISCC PLUS认证的MasmaBalance生物聚丙烯的商业化正迅速发展成为一大趋势，使医疗设备製造商能够在不改变其检验的生产基础设施的情况下，采用永续聚合物。透过采用MasmaBalance方法，供应商可以将生物基积分分配给现有的化石基生产工艺，从而确保检验的可追溯性，同时避免建造分离设施所需的高额资本投入。此方法对医疗产业至关重要，因为它克服了为高纯度等级产品建设专用生物工厂所带来的物流和经济障碍。 2024年10月，ISCC系统在循环经济相关人员大会上报告称，全球有效的ISCC PLUS认证总数已超过4800项，这表明这种支持永续性声明的管理链模式正在被工业界迅速采用。

同时，市场正发生结构性转变，第二代废弃物（例如焦油和废弃食用油残渣）正逐渐取代第一代粮食作物，成为市场主导。这项转变不仅解决了与粮食供应竞争相关的伦理问题，而且与作物衍生产品相比，显着降低了生物丙烯在其整个生命週期中的碳足迹。医疗设备製造商 (OEM) 正在加强对这些废弃物衍生原料的采用力度，以满足严格的循环经济目标，同时又不影响临床应用所需的化学可再生。例如，Neste 在截至 2024 年 3 月的财政年度报告中宣布，废弃物和残渣原料平均占其可再生原料总投入的 92%，这巩固了非粮食原料在可再生碳氢化合物聚合物生产中的主流地位。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：生物基聚丙烯医疗设备用全球市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依应用领域（心臟瓣膜结构、外科缝合线、外科网片等）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美医疗设备用生物基聚丙烯市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲医疗设备用生物基聚丙烯市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区生物基聚丙烯医疗设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲医疗设备用生物基聚丙烯市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲医疗设备用生物基聚丙烯市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球生物基聚丙烯医疗设备市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Saudi Basic Industries Corp
  • LyondellBasell Industries NV
  • Mitsui Chemicals Inc.
  • Borealis AG
  • Braskem SA
  • TotalEnergies SE
  • Danimer Scientific Inc
  • FAF Kunststofftechnik GmbH & Co KG
  • GreenMantra Recycling Technologies Ltd
  • Avient Corporation

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 20077

The Global Bio-based Polypropylene in Medical Devices Market is projected to expand from USD 11.96 Billion in 2025 to USD 20.41 Billion by 2031, reflecting a compound annual growth rate of 9.32%. Bio-based polypropylene used in medical applications is a thermoplastic polymer produced from renewable sources like corn, sugarcane, or waste oils, engineered to offer identical mechanical performance and chemical resistance to fossil-based polypropylene while diminishing carbon emissions. The central forces driving this market include the healthcare industry's urgent requirement to reduce its environmental impact and intensifying regulatory demands for sustainable procurement. These drivers indicate a foundational structural transition toward supply chain decarbonization rather than simple technological trends. As reported by European Bioplastics, global bioplastics production capacity hit 2.47 million tonnes in 2024, highlighting the growing industrial scale necessary to meet these sustainable sourcing needs.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 11.96 Billion
Market Size 2031USD 20.41 Billion
CAGR 2026-20319.32%
Fastest Growing SegmentSurgery Sutures
Largest MarketNorth America

Conversely, a major hurdle limiting widespread market growth is the stringent validation and requalification procedure mandated for medical-grade materials. Substituting traditional polypropylene with a bio-based counterpart requires comprehensive testing to guarantee regulatory compliance and biocompatibility, resulting in significant expenses and delaying market entry for established producers. Because patient safety is paramount, these bio-based alternatives must undergo extensive scrutiny before adoption, creating a barrier that slows the replacement of conventional plastics despite the clear environmental benefits.

Market Driver

The enforcement of strict regulatory frameworks advocating for sustainable materials serves as the main engine reshaping the Global Bio-based Polypropylene in Medical Devices Market. As healthcare systems aim to decarbonize, procurement mandates are aggressively requiring the reduction of Scope 3 emissions, compelling manufacturers to shift from fossil-based resources to bio-based polymers to ensure compliance and retain market access. For example, NHS England expanded its requirement for suppliers to publish a Carbon Reduction Plan to encompass all new procurements starting in April 2024, directly obliging device suppliers to prove verified emission reductions. This transition is vital given that, according to Think Global Health, the global healthcare sector accounted for approximately 4.4 percent of all greenhouse gas emissions in February 2024, highlighting the urgent need for such material changes.

Furthermore, strategic industry collaborations focused on bio-material research and commercialization are accelerating market expansion by surmounting supply chain and validation obstacles. Chemical manufacturers are partnering directly with medical device companies to create medical-grade bio-based polypropylene that satisfies strict biocompatibility requirements while increasing production capabilities. These alliances ensure that bio-based options are technically sound and commercially available in quantities adequate for mass production. Illustrating this industrial dedication, LyondellBasell reiterated its target in its 2024 Sustainability Report to manufacture and sell at least 2 million metric tons of recycled and renewable-based polymers annually by 2030. Such expansion, underpinned by strategic partnerships, is crucial for substituting conventional polypropylene in high-volume uses like packaging and disposable syringes.

Market Challenge

The comprehensive validation and requalification process necessary for medical-grade materials represents a primary barrier curbing the growth of the bio-based polypropylene market. Medical device producers must comply with rigorous safety standards, implying that replacing conventional polypropylene with a bio-based equivalent initiates mandatory, extensive testing protocols. These procedures entail thorough biocompatibility evaluations and long-term stability studies to confirm that the new material presents no threat to patient safety. The significant capital needed for this requalification, along with the unpredictability of approval timelines, compels manufacturers to favor established fossil-based supply chains over sustainable options to prevent operational interruptions.

This regulatory bottleneck markedly retards the commercialization pace of bio-based devices, generating a gap between raw material supply and actual market uptake. The prolonged period needed to navigate these regulatory obstacles effectively postpones the return on investment for firms seeking to decarbonize their product lines. As stated by MedTech Europe, the average duration to finalize the regulatory certification process for modified medical technologies under the Medical Device Regulation was reported to surpass 18 months in 2024. Such extended lead times deter manufacturers from adopting bio-based polypropylene, as the delay in market entry introduces competitive risks that supersede the immediate advantages of sustainable procurement.

Market Trends

The commercialization of ISCC PLUS Certified Mass Balance Bio-PP is swiftly developing as a major trend, enabling medical device manufacturers to incorporate sustainable polymers without modifying their validated production infrastructure. By employing a mass balance method, suppliers assign bio-based credits to existing fossil-based manufacturing streams, effectively avoiding the capital-intensive requirement for segregated facilities while guaranteeing verifiable traceability. This approach is essential for the medical industry as it overcomes the logistical and economic hurdles of building dedicated bio-plants for high-purity grades. In October 2024, the ISCC System reported during its circular economy stakeholder meeting that the global count of valid ISCC PLUS certificates exceeded 4,800, indicating the rapid industrial uptake of this chain-of-custody model to substantiate sustainable claims.

Concurrently, the market is experiencing a structural shift toward Second-Generation Waste-Derived Feedstocks, favoring residues such as tall oil and used cooking oil over first-generation food crops. This transition resolves ethical issues concerning food supply competition and substantially reduces the lifecycle carbon footprint of the resulting bio-propylene relative to crop-based options. Medical OEMs are increasingly requesting these waste-derived grades to satisfy stringent circular economy objectives without sacrificing the chemical purity needed for clinical uses. Highlighting this supply chain progression, Neste disclosed in its March 2024 Annual Report that the proportion of waste and residue feedstocks averaged 92 percent of its total renewable material inputs, solidifying the prevalence of non-food sources in renewable hydrocarbon production for polymers.

Key Market Players

  • Saudi Basic Industries Corp
  • LyondellBasell Industries NV
  • Mitsui Chemicals Inc.
  • Borealis AG
  • Braskem SA
  • TotalEnergies SE
  • Danimer Scientific Inc
  • FAF Kunststofftechnik GmbH & Co KG
  • GreenMantra Recycling Technologies Ltd
  • Avient Corporation

Report Scope

In this report, the Global Bio-based Polypropylene in Medical Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bio-based Polypropylene in Medical Devices Market, By Application

  • Heart Valve Structures
  • Surgery Sutures
  • Surgical Mesh
  • Others

Bio-based Polypropylene in Medical Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bio-based Polypropylene in Medical Devices Market.

Available Customizations:

Global Bio-based Polypropylene in Medical Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bio-based Polypropylene in Medical Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Heart Valve Structures, Surgery Sutures, Surgical Mesh, Others)
    • 5.2.2. By Region
    • 5.2.3. By Company (2025)
  • 5.3. Market Map

6. North America Bio-based Polypropylene in Medical Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Bio-based Polypropylene in Medical Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
    • 6.3.2. Canada Bio-based Polypropylene in Medical Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
    • 6.3.3. Mexico Bio-based Polypropylene in Medical Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application

7. Europe Bio-based Polypropylene in Medical Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Bio-based Polypropylene in Medical Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
    • 7.3.2. France Bio-based Polypropylene in Medical Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
    • 7.3.3. United Kingdom Bio-based Polypropylene in Medical Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
    • 7.3.4. Italy Bio-based Polypropylene in Medical Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
    • 7.3.5. Spain Bio-based Polypropylene in Medical Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application

8. Asia Pacific Bio-based Polypropylene in Medical Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Bio-based Polypropylene in Medical Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
    • 8.3.2. India Bio-based Polypropylene in Medical Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
    • 8.3.3. Japan Bio-based Polypropylene in Medical Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
    • 8.3.4. South Korea Bio-based Polypropylene in Medical Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
    • 8.3.5. Australia Bio-based Polypropylene in Medical Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application

9. Middle East & Africa Bio-based Polypropylene in Medical Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Bio-based Polypropylene in Medical Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
    • 9.3.2. UAE Bio-based Polypropylene in Medical Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
    • 9.3.3. South Africa Bio-based Polypropylene in Medical Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application

10. South America Bio-based Polypropylene in Medical Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Bio-based Polypropylene in Medical Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
    • 10.3.2. Colombia Bio-based Polypropylene in Medical Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
    • 10.3.3. Argentina Bio-based Polypropylene in Medical Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Bio-based Polypropylene in Medical Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Saudi Basic Industries Corp
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. LyondellBasell Industries NV
  • 15.3. Mitsui Chemicals Inc.
  • 15.4. Borealis AG
  • 15.5. Braskem SA
  • 15.6. TotalEnergies SE
  • 15.7. Danimer Scientific Inc
  • 15.8. FAF Kunststofftechnik GmbH & Co KG
  • 15.9. GreenMantra Recycling Technologies Ltd
  • 15.10. Avient Corporation

16. Strategic Recommendations

17. About Us & Disclaimer